HIV vaccine study for people on effective treatment
Part of Immune system & allergy, Infections clinical trials.
This study tests a new vaccine designed to help your immune system fight HIV better. It is for people with HIV who are already on effective antiretroviral therapy and have a well-controlled virus. The goal is to see if the vaccine is safe and boosts your body's natural defenses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have HIV and have been on antiretroviral therapy (ART) for at least 1 year, with your viral load under 50 copies/ml.
- Your CD4 count is above 250.
- You have not received an experimental HIV vaccine or anti-HIV antibody before.
- You are not pregnant and are willing to use effective contraception if needed.
- You are enrolled in the Swiss HIV Cohort Study (SHCS).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of an HIV vaccine and a new antibody treatment (GS-2872) to see if it can help control HIV without daily pills. It is for people with well-controlled HIV who are looking for ways to reduce their dependence on antiretroviral therapy.
This trial tests a new combination HIV vaccine in healthy adults to see if it is safe and produces an immune response. If you are at low risk for HIV, you may help researchers learn more about future prevention strategies.
This Phase 1 trial tests two new HIV vaccines (DV700P-RNA and DV701B1.1-RNA) combined with a monitored break from HIV medications in people with well-controlled HIV. The goal is to see if this approach safely strengthens the immune system's ability to fight HIV.
This study tests a new DNA vaccine (ICVAX) designed to help your immune system better control HIV. You'll receive injections over several months if your HIV is well-controlled with current medications.
This trial tests an experimental HIV vaccine to see if it is safe and triggers an immune response. It is for healthy adults who are HIV-negative and at low risk for HIV.
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
Hear when a new People Living With HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.